You are here

AstraZeneca

AstraZeneca pulls back the corporate curtain to highlight real people and chat complex science

Endpoints

Sun, 02/26/23 - 10:18 pm

AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences

Medical Marketing and Media

Fri, 02/24/23 - 09:16 am

antibody-drug conjugate

KYM Biosciences

AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal

Fierce Biotech

Thu, 02/23/23 - 10:00 am

KYM Biosciences

antibody-drug conjugate

pancreatic cancer

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Fierce Pharma

Tue, 02/21/23 - 10:26 am

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

Forbes

Mon, 02/20/23 - 12:37 pm

Moderna Therapeutics

Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop

Fierce Biotech

Fri, 02/10/23 - 10:43 am

Aristea Therapeutics

AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030

Endpoints

Thu, 02/9/23 - 06:33 pm

Lower COVID sales weigh on AZ in fourth quarter

Pharmaphorum

Thu, 02/9/23 - 10:51 am

AstraZeneca's Forxiga nabs expanded heart failure approval in Europe

Fierce Pharma

Tue, 02/7/23 - 06:41 pm

Roche races to regulators after matching AstraZeneca's rare disease blockbuster in phase 3

Fierce Biotech

Tue, 02/7/23 - 11:04 am

AstraZeneca gets personal

EP Vantage

Tue, 01/31/23 - 10:26 am

personalized medicine

AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS

Endpoints

Mon, 01/30/23 - 05:58 pm

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Tue, 01/24/23 - 06:31 pm

Bristol Myers Squibb

AstraZeneca, Merck go multilingual for prostate cancer push

Medical Marketing and Media

Mon, 01/23/23 - 09:54 pm

pharma marketing

prostate cancer

AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market

MPR

Thu, 01/12/23 - 09:23 pm

Biopharma’s bolt-on bonanza is set to continue

EP Vantage

Thu, 01/12/23 - 10:18 am

Bristol Myers Squibb

JPM23: Ionis CEO admits PCSK9 ship captained by Big Pharmas may have sailed

Fierce Biotech

Wed, 01/11/23 - 11:02 pm

Ionis Pharmaceuticals

AstraZeneca and Avillion win approval for new asthma rescue treatment in adults

Endpoints

Wed, 01/11/23 - 10:53 am

Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting

BioPharma Dive

Mon, 01/9/23 - 10:43 am

Chiesi Farmaceutici

AstraZeneca Buys CinCor in a Deal Worth Up to $1.8B

BioSpace

Mon, 01/9/23 - 10:41 am

Pages